Format

Send to

Choose Destination
FEBS Lett. 2014 Mar 3;588(5):641-52. doi: 10.1016/j.febslet.2013.12.038. Epub 2014 Jan 31.

The dark sides of amyloid in Alzheimer's disease pathogenesis.

Author information

1
Dipartimento di Neuroscienze e Scienze Riproduttive ed Odontostomatologiche, Università degli Studi di Napoli Federico II, Naples, Italy.
2
Dipartimento di Scienze Motorie e del Benessere, Università degli Studi di Napoli Parthenope, Naples, Italy; Istituto di Diagnosi e Cura Hermitage Capodimonte, Naples, Italy.
3
Dipartimento di Scienze Motorie e del Benessere, Università degli Studi di Napoli Parthenope, Naples, Italy; Istituto di Diagnosi e Cura Hermitage Capodimonte, Naples, Italy. Electronic address: giuseppe.sorrentino@uniparthenope.it.

Erratum in

  • FEBS Lett. 2014 Dec 20;588(24):4838.

Abstract

Although widely explored, the pathogenesis of Alzheimer's disease (AD) has yet to be cleared. Over the past twenty years the so call amyloid cascade hypothesis represented the main research paradigm in AD pathogenesis. In spite of its large consensus, the proposed role of β-amyloid (Aβ) remain to be elucidated. Many evidences are starting to cast doubt on Aβ as the primary causative factor in AD. For instance, Aβ is deposited in the brain following many different kinds of injury. Also, concentration of Aβ needed to induce toxicity in vitro are never reached in vivo. In this review we propose an amyloid-independent interpretation of several AD pathogenic features, such as synaptic plasticity, endo-lysosomal trafficking, cell cycle regulation and neuronal survival.

KEYWORDS:

Alzheimer’s disease; Amyloid; Cell cycle regulation; Endo-lysosomal trafficking; Neuronal survival; Presenilin; Synaptic plasticity

PMID:
24491999
DOI:
10.1016/j.febslet.2013.12.038
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center